Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2025
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Advanced Melanoma - Pipeline Insight, 2025
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Advanced Melanoma: Understanding Advanced Melanoma: ... Read More
-
Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC)
... are currently ten actionable genomic alterations (AGAs) that are addressed by targeted therapy agents across multiple lines of therapy. Patients who did not undergo genetic testing or tested negative for AGAs, receive immunotherapy agents depending ... Read More
-
Cancer Supportive Care Drugs Global Market Report 2025
... care drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034
... incident cases, label expansion and penetration of current therapies in earlier lines, high adoption of newer therapies mainly CAR-T cell therapies and anti-BCMA, rich emerging pipeline, and expected increase in investment in the R&D activities ... Read More
-
Cancer Care (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Cancer Care (UK) report will tell you the companies that have ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025
... immunotherapy drug discovery outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2025-2033
... 2025-2033. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women’s health through numerous campaigns and initiatives by the ... Read More
-
2025 Global Gene Therapy For Cancer Market Industry (2031 Outlook)
... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More
-
Refractory Metastatic Melanoma - Pipeline Insight, 2025
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Refractory Metastatic Melanoma: ... Read More
-
Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2025
... Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Squamous Non-Small Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Global Lymphedema Treatment Market, By Product Type (Compression Garments and Wraps, Compression Pumps, Manual Lymph Drainage Devices, Others), By Type (Primary Lymphedema, Secondary Lymphedema), By Extremities (Upper Body, Lower Body, Head and Neck), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare Settings, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... a person's quality of life. This condition can occur due to various factors, such as damage to the lymphatic system during cancer treatment, surgery, infection, or genetic predisposition. Market Dynamics: Global lymphedema treatment market is ... Read More
-
Virtual Oncology Market, By Component (Software, Service, Hardware), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Others (Pancreatic, Ovarian, etc.)), By Application (Precision Medicine, Patient Care Management, Research & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract Research Organizations (CROs), Others (Reference Laboratories, Pharmacies etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... The aim of virtual oncology is to improve patient outcomes, increase access to care, and enhance the overall patient experience. With advancements in technology and the increasing prevalence of cancer worldwide, virtual oncology has gained ... Read More
-
Fecal Calprotectin Test Market, By Assay Type (Enzyme Linked Immunosorbent Assay (ELISA), Enzyme Fluoroimmunoassay, and Quantitative Immune-Chromatography), By Indication (Inflammatory Bowel Disease (IBD) Diagnosis, Colorectal Cancer, Celiac Disease, and others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and others), , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... making it a helpful biomarker for identifying and tracking the condition. Market Dynamics: The increasing prevalence of gastrointestinal disorders, growing awareness and early detection, and non-invasive and convenient testing are anticipated to drive growth of ... Read More
-
Genomic Cancer Testing Market, By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Other healthcare providers), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Molecular Biomarkers, Epigenetic Biomarkers), By Service Provider (Diagnostic Laboratories, Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations), By Application (Targeted Therapy Selection, Disease Monitoring, Prognostic Testing, Companion Diagno
... tailor treatment based on an individual’s genetic profile and select therapeutics that directly target the abnormalities present. The genomic analysis of a tumor helps predict response to certain drugs, checks for genetic markers that may ... Read More
-
Physician Office Diagnostic Market, By Product Type (Point-of-Care Testing (POCT) Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, and Urinalysis Systems), By End User (Physician Offices and Clinics, Urgent Care Centers, and Ambulatory Care Centers), By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... are anticipated to drive growth of the global physician office diagnostic market over the forecast period. Moreover, increasing focus on personalized medicine is also expected to boost growth of the global physician office diagnostic market ... Read More
-
Genomic Cancer Panel and Profiling Market - A Global and Regional Analysis: Focus on Tissue Testing, Cancer Panel Type, Cancer Type, Application, Technology, End User, and Region - Analysis and Forecast, 2025-2035
... prevalence of cancer worldwide, coupled with the growing demand for personalized treatment approaches, has accelerated the adoption of genomic cancer panels for early diagnosis, prognosis, and therapy selection. According to the data published by the ... Read More
-
Canada Clinical Nutrition Market, By Nutrition Type (Enteral Nutrition (Standard Nutrition, Disease Specific Nutrition), Parenteral Nutrition (Amino Acid, Carbohydrates, Vitamins and Minerals, Others (Proteins, Lipids among Others))), By Form (Powder, Liquid, Tablets, Capsules, Gummies, Others (Nutrition Bar, among Others)), By Route of Administration (Oral, Enteral, Parenteral), By Age Group (Infant Nutrition, Adult Nutrition, Geriatric Nutrition), By Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other (Cardiovascular Diseases and Others)), By End User (Hospitals, Ambulatory Surgical Centers, Long Term Care Facilities)
... plays an important role in the human body, deficiency of essential nutrients could lead to various problems, such as anemia, diabetes, and blood disorder. Clinical nutrition products help to improve metabolism, digestion, absorption, and storage ... Read More
-
Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions
... of development and its mechanisms of metastasis and recurrence. It also incorporates the disease burden by knowing the epidemiology of different cancers. Treatment patterns that include both non-pharmacological (e.g., radiation, surgery) and pharmacological (e.g., hormonal ... Read More
-
Implantable Port Market Research Report by Type (Silicone, Polyurethane, Titanium), By Application (Chemotherapy, Antibiotic Therapy, Total Parenteral Nutrition, Blood Transfusion), By End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics), By Insertion Method (Surgical Insertion, Percutaneous Insertion) Industry Forecast to 2035
... - 2035). The rising prevalence of chronic diseases worldwide is one of the primary drivers pushing the growth of the Implantable Port Market Industry. As diseases such as cancer, diabetes, and renal disorders become more ... Read More
-
Oncology Precision Medicine Market by Type of Cancer Targeted
... CAGR of 8.5% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Cancer Targeted Bladder Cancer Blood / Hematologic Cancer Breast Cancer Cervical ... Read More
-
Bispecific Antibodies Market by Therapeutic Area
... 9.5% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Therapeutic Area Autoimmune Disorders Genetic Disorders Hematological Malignancies Ophthalmic Disorders Skin Cancers Solid Tumors Mechanism ... Read More
-
Liquid Biopsy Market by Application
... 15.53% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Application Early Cancer Diagnosis Patient Monitoring Recurrence Monitoring Target Disease Indication Breast Cancer Gastric Cancer ... Read More
-
Cytotoxic Drugs & HPAPI Manufacturing Market by Type of Product
... by 2035, at a CAGR of 11.6% during the forecast period, till 2035. The market opportunity for cell and gene therapy supply chain software has been distributed across the following segments: Type of Product HPAPIs ... Read More
-
Cancer Biomarkers Market by Type of Biomarker
... 5% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Biomarker HER2 MET EGFR PD-L1 NTRK ALK Novel Biomarkers Other Biomarkers Type of ... Read More
Research Assistance
